To evaluate the role of RRM2 as a prognostic biomarker in breast cancer, we analyzed the relationship between the expression level of RRM2 in the METABRIC database and the overall survival and DMFS of patients with breast cancer. The gene discussed is RRM2; the disease is breast cancer.